Delphine Diagnostics participated in Fierce JPM Week Virtual 2026, a leading healthcare and biopharma event bringing together industry leaders, innovators, and investors.
The conference featured discussions on AI, emerging scientific advancements, regulatory developments, dealmaking, and the future of healthcare innovation, providing valuable insights into the evolving life sciences landscape.